Company name: eNose
Description: Operator of a medical technology platform intended to focus on disease screening using exhaled-breath analysis. The company’s platform develops, manufactures and markets an electronic nose technology, enabling clients to analyses the breath pattern, measure deviation and detect gases, chemicals, cannabis and diseases in humans and animals.
Year founded: 2013
Industry: Healthcare | Group: Healthcare Devices and Supplies | Code:
Start up capital raised (USD Million): 0.36
Business status: Generating Revenue
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company received an undisclosed amount of financing from VSD Logistics on December 15, 2015.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation:
Last known valuation date: